Promoter variants for expressing genes in a fungal cell

US9873881B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9873881-B2
Application numberUS-201715498011-A
CountryUS
Kind codeB2
Filing dateApr 26, 2017
Priority dateNov 18, 2002
Publication dateJan 23, 2018
Grant dateJan 23, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to methods for producing a biological substance, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the biological substance, wherein the fungal host cell comprises a first nucleic acid sequence encoding the biological substance operably linked to a second nucleic acid sequence comprising a promoter variant selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, and SEQ ID NO: 12; and a subsequence thereof; and hybrid and tandem promoters thereof; and (b) isolating the biological substance from the cultivation medium. The present invention also relates to the isolated promoter variants and to constructs, vectors, and fungal host cells comprising the promoter variants operably linked to nucleic acid sequences encoding biological substances.

First claim

Opening claim text (preview).

What is claimed is: 1. An isolated promoter variant comprising SEQ ID NO: 2. 2. The promoter variant of claim 1 , which increases expression of a nucleic acid sequence encoding a polypeptide compared to the parent promoter of SEQ ID NO: 1. 3. A nucleic acid construct comprising a nucleic acid sequence encoding a polypeptide operably linked to the promoter variant of claim 1 . 4. A recombinant expression vector comprising the nucleic acid construct of claim 3 . 5. A recombinant host cell comprising the nucleic acid construct of claim 3 . 6. A method for producing a polypeptide, comprising: (a) cultivating a fungal host cell in a medium conducive for producing the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising the promoter variant of claim 1 ; and (b) isolating the polypeptide from the cultivation medium. 7. The method of claim 6 , wherein the promoter variant comprising SEQ ID NO: 2 increases expression of the first nucleic acid sequence compared to the parent promoter of SEQ ID NO: 1. 8. The method of claim 6 , wherein the fungal host cell contains one or more copies of the first nucleic acid sequence. 9. The method of claim 6 , wherein the fungal host cell contains one copy of the first nucleic acid sequence. 10. The method of claim 6 , wherein the polypeptide is selected from the group consisting of an antigen, enzyme, growth factor, hormone, immunodilator, neurotransmitter, receptor, reporter protein, structural protein, and transcription factor. 11. The method of claim 6 , wherein the polypeptide is native to the fungal host cell. 12. The method of claim 6 , wherein the polypeptide is foreign to the fungal host cell. 13. A method for producing a polypeptide, comprising (a) cultivating a homologously recombinant cell, having incorporated therein an introduced transcription unit comprising the promoter variant of claim 1 , an exon, and/or a splice donor site operably linked to a second exon of an endogenous nucleic acid sequence encoding the polypeptide, under conditions conducive for production of the polypeptide; and (b) recovering the polypeptide.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9873881B2 cover?
The present invention relates to methods for producing a biological substance, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the biological substance, wherein the fungal host cell comprises a first nucleic acid sequence encoding the biological substance operably linked to a second nucleic acid sequence comprising a promoter variant selected from the …
Who is the assignee on this patent?
Novozymes Inc
What technology area does this patent fall under?
Primary CPC classification C12N15/80. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).